A Reuters article republished by Bangkok Post titled, “Thailand to make, supply AstraZeneca’s Covid-19 vaccine” would claim that Thailand has agreed to make AstraZeneca’s COVID-19 vaccine.
This is despite the vaccine not only not having passed clinical trials or having been determined to be safe or effective yet – but despite AstraZeneca’s long history of corruption, bribery, and the overall danger of Western pharmaceutical giants who use lobbying to push dangerous, unnecessary products past regulators and onto the public.
AstraZeneca’s vaccine has already made news by possibily creating neurological disorders in patients involved in clinical trials.
While both AstraZeneca and Western regulators dismissed the incident – it is not certain whether this is because the condition was truly unrelated to the ongoing vaccine trial – or because AstraZeneca simply bribed regulators to ignore it.
It is unclear because AstraZeneca along with the entirety of the Western pharmaceutical industry are notoriously corrupt and each investigated and fined multiple times around the globe for massive bribery campaigns aimed at everything from boosting sales, to having dangerous products approved for sale, to money paid to close investigations into their business practices or the dangers their products present to the public’s health.
AstraZeneca – developing its candidate for a COVID-19 vaccine with billions in US government funding – is guilty – not suspected of or accused of – but guilty of bribery in multiple countries and has been fined by the US government itself.
Legal measures have been put in place to protect pharmaceutical giants like AstraZeneca from lawsuits that will arise if their COVID-19 vaccine fails to work, or even harms the health of those given it.
AstraZeneca’s COVID-19 vaccine rewrites genetic information in human cells – and would be the first and widest distribution of such technology. This is an unimaginably reckless rollout for what is completely unproven technology with no long-term studies on safety available because no such technology has been used before or on such a large scale.
Considering AstraZeneca’s background – no corporation could be less qualified or less trustworthy to rollout such a risky product.COVID-19 Vaccine Partnership with AstraZeneca: A Threat to Public Health